Upload Avatar (500 x 500)
Chenguang Shen
Public Health
Southern Medical University
Guangdong
Language: Chinese, English
Antibodies
Vaccines
Human Pathogens
Therapeutic
Preventive
Diagnostic
Animal-Derived Antibodies
Human-Derived Antibodies
Disease Mechanisms
Biological Products
Areas of Focus
- Research on human pathogen antibodies and vaccines
Academic Background & Achievements
- Doctorate: Not mentioned
- Achievement: Shenzhen Science and Technology Progress Second Prize
Publications
- Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, Chenguang Shen*, Zhaoqin Wang*, Fang Zhao*, Yang Yang*, Jinxiu Li, Jing Yuan, Fuxiang Wang, Delin Li, Minghui Yang, Li Xing, Jinli Wei, Haixia Xiao, Yan Yang, Jiuxin Qu, Ling Qing, Li Chen, Zhixiang Xu, Ling Peng, Yanjie Li, Haixia Zheng, Feng Chen, Kun Huang, Yujing Jiang, Dongjing Liu, Zheng Zhang#, Yingxia Liu#, Lei Liu#, 2020
- A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Yan Wu*, Feiran Wang*, Chenguang Shen*, Weiyu Peng*, Delin Li*, Cheng Zhao, Zhaohui Li, Shihua Li, Yuhai Bi, Yang Yang, Yuhuan Gong, Haixia Xiao, Zheng Fan, Shuguang Tan, Guizhen Wu, Wenjie Tan, Xuancheng Lu, Changfa Fan, Qihui Wang, Yingxia Liu, Chen Zhang, Jianxun Qi, George Fu Gao#, Feng Gao#, Lei Liu#, 2020
- A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses, Chenguang Shen*, Junyu Chen*, Rui Li*, Mengya Zhang*, Guosong Wang*, Svetlana Stegalkina, Limin Zhang, Jing Chen, Jianli Cao, Xingjian Bi1,2, Stephen F. Anderson, Timothy Alefantis, Qingbing Zheng, Mujing Fang, Kunyu Yang, Hai Yu, Wenxin Luo, Zizheng Zheng, Quan Yuan, Jun Zhang, J. Wai-Kuo Shih, Harold Kleanthous, Honglin Chen, Yixin Chen#, Ningshao Xia#
- An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency, Chenguang Shen*, Minwei Zhang*, Yuanzhi Chen*, Limin Zhang, Guosong Wang, Junyu Chen, Siyuan Chen, Zizhen Li, Feixue Wei, Jing Chen, Shuxin Guo, Yujing Wang, Qingbing Zheng, Hai Yu, Wenxin Luo, Jun Zhang, Honglin Chen, Yixin Chen#, Ningshao Xia
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19, Yang Yang*, Chenguang Shen*, Jinxiu Li*, Jing Yuan, Jinli Wei, Fengmin Huang, Fuxiang Wang, Guobao Li, Yanjie Li, Li Xing, Ling Peng, Minghui Yang, Mengli Cao, Haixia Zheng, Weibo Wu, Rongrong Zou, Delin Li, Zhixiang Xu, Haiyan Wang, Mingxia Zhang, Zheng Zhang, Chengyu Jiang#, Lei Liu#, Yingxia Liu#
- Virus‐free and live‐cell visualizing SARS‐CoV‐2 cell entry for studies of neutralizing antibodies and compound inhibitors, Yali Zhang*, Shaojuan Wang*, Yangtao Wu*, Wangheng Hou*, Lunzhi Yuan*, Chenguang Shen*, Juan Wang, Jianghui Ye, Qingbing Zheng, Jian Ma, Jingjing Xu, Min Wei, Zonglin Li, Sheng Nian, Hualong Xiong, Liang Zhang, Yang Shi, Baorong Fu, Jiali Cao, Chuanlai Yang, Zhiyong Li, Ting Yang, Lei Liu, Hai Yu, Jianda Hu, Shengxiang Ge, Yixin Chen, Tianying Zhang, Jun Zhang, Tong Cheng#, Quan Yuan#, Ningshao Xia#
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19, Chuang Liu*, Luiza Mendonça*, Yang Yang*, Yuanzhu Gao*, Chenguang Shen*, Jiwei Liu, Tao Ni, Bin Ju, Congcong Liu, Xian Tang, Jinli Wei, Xiaomin Ma, Yanan Zhu, Weilong Liu, Shuman Xu, Yingxia Liu, Jing Yuan, Jing Wu, Zheng Liu, Zheng Zhang#, Lei Liu#, Peiyi Wang#, Peijun Zhang#, 2020
- Clinical and virological characteristics of human infections with H7N9 avian influenza virus in Shenzhen, China, 2013-2017, Yang Yang*, Chenguang Shen*, Jin Li*, Rongrong Zou, Gary Wong, LingPeng, Liuqing Yang, Shisong Fang, Jianming Li, Xiaohe Li, Weibo Wu, XiaoJiang, Lijiao Zeng, Jianfeng Lan, Yuhai Bi, George F. Gao, Jing Yuan#, Yingxia Liu#
- Clinical and virological characteristics of human infections with H7N9 avian influenza virus in Shenzhen, China, 2013-2017, HuaLong Xiong*, JiaLi Cao*, ChenGuang Shen*, Jian Ma, XiaoYang Qiao, TianShu Shi, ShengXiang Ge, HuiMing Ye, Jun Zhang, Yuan Quan#, TianYing Zhang# and NingShao Xia#
- Intra-host diversity of hepatitis B virus during mother-to-child transmission: the X gene may play a key role in virus survival in children after transmission, Yanjie Li*, Chenguang Shen*, Liuqing Yang*, Yang Yang, Miao Wang, Shanqin Li, FengChen, Min Yang, Ling Peng, Jinmin Ma, Zhongping Duan#, Liqiang Li#, Yingxia Liu#, 2020
- Virus-mimetic nanovesicles as a versatile antigen-delivery system, Pengfei Zhang*, Yixin Chen*, Yun Zeng*, Chenguang Shen, Rui Li, Zhide Guo, Shaowei Li, Qingbing Zheng, Chengchao Chu, Zhantong Wang, Zizheng Zheng, Rui Tian, Shengxiang Ge, Xianzhong Zhang, Ning-Shao Xia, Gang Liu#, and Xiaoyuan Chen#
- Rapid identification of imported influenza viruses at Xiamen International Airport via an active surveillance program, J. Chen*, K. Yang*, M. Zhang#, C. Shen, J. Chen, G. Wang, S. Huang, M. Zhang, H. Xiong, H. Chen, Y. Chen#, N. Xia
- Experimental treatment with favipiravir for COVID-19: an open-label control study, Qingxian Cai*, Minghui Yang*, Dongjing Liu*, Jun Chen*, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang, Chenguang Shen, Xiaohe Li, Ling Peng, Deliang Huang, Jing Zhang, Shurong Zhang, Fuxiang Wang, Jiaye Liu, Li Chen, Shuyan Chen, Zhaoqin Wang, Zheng Zhang, Ruiyuan Cao, Wu Zhong#, Yingxia Liu#, Lei Liu#
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury, Y. Liu*, C. Zhang*, F. Huang*, F. Yang*, F. Wang, J. Yuan, Z. Zhang, Y. Qin, X. Li, D. Zhao, S. Li, S. Tan, Z. Wang, J. Li, C. Shen, J. Li, L. Peng, W. Wu, M. Cao, L. Xing, Z. Xu, L. Chen, C. Zhou, W. Liu#, L. Liu#, C. Jiang#
- Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates, Peng TT*, Cai QE*, Yang M*, Chen SP, Chen F, Wang M, Peng L, Wong G, Shen CG, Cheng WB, Liu SY, Peng YB, Peng JH, Chen CM, Yang LQ, Tang YM, Xu ZX, Liu YX#
- An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2, Gui X*, Li R*, Zhang X, Shen C, Yu H, Guo X, Kang Y, Chen J, Chen H, Chen Y#, Xia N#
- Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test, Jianghong An*, Xuejiao Liao*, Tongyang Xiao*, Shen Qian, Jing Yuan, Haocheng Ye, Furong Qi, Chengguang Shen, Lifei Wang, Yang Liu, Xiaoya Cheng, Na Li, Qingxian Cai, Fang Wang, Jun Chen, Guojun Li, Qiu’e Cai, Yingxia Liu, Yunfang Wang, Feng Zhang, Yang Fu, Qing He, Xiaohua Tan#, Lei Liu#, and Zheng Zhang#
- Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection, Yang Yang*, Minghui Yang*, Jing Yuan*, Fuxiang Wang*, Zhaoqin Wang, Jinxiu Li, Mingxia Zhang, Li Xing, Jinli Wei, Ling Peng, Gary Wong, Haixia Zheng, Weibo Wu, Chenguang Shen, Mingfeng Liao, Kai Feng, Jianming Li, Qianting Yang, Juanjuan Zhao, Lei Liu#, Yingxia Liu#
- Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells, Yang, M*, Wei, J*, Huang, T, Lei, L, Shen, C, Lai, J, Yang, M, Liu, L, Yang, Y#, Liu, G#, & Liu, Y#
Awards
- Shenzhen Science and Technology Progress Second Prize
